Elidel and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elidel (pimecrolimus) and Glipizide (glipizide). Common drug interactions include pancreatitis acute among females and atrioventricular block first degree among males.

The phase IV clinical study analyzes what interactions people have when they take Elidel and Glipizide. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.



On Jul, 19, 2026

25 people who take Elidel and Glipizide together, and have interactions are studied.

Elidel and Glipizide drug interactions.

What are the common drug interactions of Elidel and Glipizide, by gender? *:

female:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Drug ineffective
  3. Flushing (the warm, red condition of human skin)
  4. Metastases to lung (cancer spreads to lung)
  5. Neoplasm progression (growth of tumour)
  6. Swelling
  7. Eye swelling
  8. Injection site pain
  9. Anxiety
  10. Arthralgia (joint pain)

male:

  1. Atrioventricular block first degree (heart block first degree)
  2. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  3. Mitral valve incompetence (inefficient heart valve)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Prostatism (symptom complex resulting from compression or obstruction of the urethra, due most commonly to nodular hyperplasia of the prostate)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Tricuspid valve incompetence (inefficient heart valve)
  8. Weight decreased
  9. Weight increased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the common drug interactions of Elidel and Glipizide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Retching (strong involuntary effort to vomit)
  2. Visual acuity reduced (reduced clearness of vision)
  3. Visual impairment
  4. Arthralgia (joint pain)
  5. Chest pain
  6. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  7. Pancreatitis acute (sudden inflammation of pancreas)
  8. Abdominal adhesions (inflammation of abdomen)
  9. Abnormal loss of weight
  10. Adhesion

60+:

  1. Abdominal discomfort
  2. Blood potassium increased
  3. Ear infection
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Haemoglobin decreased
  6. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  7. Leukaemia (blood or bone marrow cancer)
  8. Leukocytosis (increased white blood cells)
  9. Local swelling (swelling at the site of some application of substance or injury)
  10. Mood altered (changes in mood)

What are the existing conditions these people have? *

  1. Pain: 3 people, 12.00%
  2. High Blood Pressure: 3 people, 12.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
  4. Sleep Disorder: 2 people, 8.00%
  5. Skin Disorder (skin disease): 2 people, 8.00%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.00%
  7. Psoriasis (immune-mediated disease that affects the skin): 2 people, 8.00%
  8. Itching: 2 people, 8.00%
  9. Irritable Bowel Syndrome: 2 people, 8.00%
  10. Hiv Infection: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and Glipizide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elidel and Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elidel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus and glipizide (the active ingredients of Elidel and Glipizide, respectively), and Elidel and Glipizide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: